Location: Menlo Park, CA
CIK: 0001631134 · Show all filings
Period: Q2 2019 (← Previous) (Next →)
Filing Date: Aug 13, 2019
Total Value: $1.088B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| ASND | Ascendis Pharma A/S | 1,099,824 | $127M | 11.6% | $115.15 | $69.98 | — | ADR | 04351P101 |
| — | Amarin | 5,208,305 | $101M | 9.3% | $19.39 | $7.81 | — | ADR | 023111206 |
| NTRA | Natera | 3,100,560 | $85.51M | 7.9% | $27.58 * | $9.81 | +124.9% | COMM | 632307104 |
| — | Principia Biopharma | 2,038,208 | $67.65M | 6.2% | $33.19 | $28.92 | — | COMM | 74257L108 |
| — | ObsEva SA | 4,749,623 | $53.72M | 4.9% | $11.31 | $13.49 | — | COMM | H5861P103 |
| — | Spark Therapeutics | 481,270 | $49.27M | 4.5% | $102.38 | $66.59 | — | COMM | 84652J103 |
| — | Y-mAbs Therapeutics, Inc | 2,104,278 | $48.13M | 4.4% | $22.87 | $26.56 | — | COMM | 984241109 |
| CHRS | Coherus BioSciences | 2,093,221 | $46.26M | 4.3% | $22.10 * | $10.94 | +58.7% | COMM | 19249H103 |
| — | Nextcure, Inc | 2,521,856 | $37.78M | 3.5% | $14.98 | $14.98 | — | COMM | 65343E108 |
| — | Audentes Therapeutics | 933,640 | $35.35M | 3.2% | $37.86 | $30.05 | — | COMM | 05070R104 |
| — | Karuna Therapeutics, Inc. | 1,729,352 | $34.62M | 3.2% | $20.02 | $20.02 | — | COMM | 48576A100 |
| — | Merus N.V. | 1,961,039 | $28.73M | 2.6% | $14.65 | $18.53 | — | COMM | N5749R100 |
| — | Nucana Biomed Ltd | 2,400,000 | $24.91M | 2.3% | $10.38 | $19.00 | — | Ordinary Shares | GB00BYWYV |
| — | Nucana Biomed Ltd | 2,266,666 | $23.53M | 2.2% | $10.38 | $15.80 | — | ADR | 67022C106 |
| PTCT | PTC Therapeutics Inc | 368,903 | $16.6M | 1.5% | $45.00 * | $39.49 | 0.0% | COMM | 69366J200 |
| NVO | Novo Nordisk A/S | 323,697 | $16.52M | 1.5% | $51.04 | $52.01 | — | ADR | 670100205 |
| — | Allergan plc | 84,433 | $14.14M | 1.3% | $167.42 | $146.41 | — | COMM | G0177J108 |
| NBIX | Neurocrine Biosciences Inc | 155,860 | $13.16M | 1.2% | $84.43 * | $87.99 | -6.7% | COMM | 64125C109 |
| — | Kiniksa Pharmaceuticals, Ltd | 922,700 | $12.49M | 1.1% | $13.54 | $17.35 | — | COMM CL A | G5269C101 |
| — | Chiasma | 1,630,221 | $12.18M | 1.1% | $7.47 | $1.49 | — | COMM | 16706W102 |
| — | Iterum Therapeutics | 1,726,514 | $11.88M | 1.1% | $6.88 | $10.89 | — | COMM | G6333L101 |
| HALO | Halozyme Therapeutics Inc | 690,199 | $11.86M | 1.1% | $17.18 * | $16.18 | -0.2% | COMM | 40637H109 |
| HRTX | Heron Therapeutics Inc | 617,185 | $11.47M | 1.1% | $18.59 * | $25.45 | -21.5% | COMM | 427746102 |
| TGTX | TG Therapeutics Inc | 1,261,384 | $10.91M | 1.0% | $8.65 * | $6.96 | +8.6% | COMM | 88322Q108 |
| — | Reata Pharmaceuticals Inc | 115,536 | $10.9M | 1.0% | $94.35 | $72.82 | — | COMM | 75615P103 |
| — | Acceleron Pharma Inc | 241,043 | $9.902M | 0.9% | $41.08 | $41.08 | — | COMM | 00434H108 |
| MGNX | MacroGenics Inc | 550,443 | $9.341M | 0.9% | $16.97 | $16.97 | +1.2% | COMM | 556099109 |
| — | MorphoSys AG | 96,135 | $9.231M | 0.8% | $96.02 | $101.67 | — | COMM | D55040105 |
| VRTX | Vertex Pharmaceuticals Inc | 50,301 | $9.225M | 0.8% | $183.40 * | $174.82 | 0.0% | COMM | 92532F100 |
| — | Amgen Inc | 50,000 | $9.214M | 0.8% | $184.28 | — | — | Put | 031162950 |
| — | Allergan plc | 50,000 | $8.372M | 0.8% | $167.44 | — | — | Call | G0177J908 |
| BMY | Bristol-Myers Squibb Co | 173,849 | $7.884M | 0.7% | $45.35 * | $36.12 | 0.0% | COMM | 110122108 |
| — | Entasis Therapeutics Holdings Inc. | 1,180,178 | $7.612M | 0.7% | $6.45 | $10.88 | — | COMM | 293614103 |
| FOLD | Amicus Therapeutics Inc | 583,309 | $7.279M | 0.7% | $12.48 | $12.97 | -2.2% | COMM | 03152W109 |
| BMRN | Biomarin Pharmaceutical Inc | 84,896 | $7.272M | 0.7% | $85.66 | $87.63 | -2.4% | COMM | 09061G101 |
| — | Dermira Inc | 659,882 | $6.309M | 0.6% | $9.56 | $10.16 | — | COMM | 24983L104 |
| INCY | Incyte Corp | 69,612 | $5.914M | 0.5% | $84.96 * | $68.57 | +17.0% | COMM | 45337C102 |
| — | Synlogic Inc. | 574,972 | $5.232M | 0.5% | $9.10 | $9.38 | — | COMM | 87166L100 |
| — | Orchard Therapeutics PLC | 365,469 | $5.113M | 0.5% | $13.99 | $15.62 | — | ADR | 68570P101 |
| — | Kadmon Holdings Inc | 2,204,202 | $4.54M | 0.4% | $2.06 | $2.78 | — | COMM | 48283N106 |
| — | Bristol-Myers Squibb Co | 100,000 | $4.534M | 0.4% | $45.34 | — | — | Call | 110122908 |
| ACRS | Aclaris Therapeutics | 1,911,573 | $4.186M | 0.4% | $2.19 * | $19.07 | -71.4% | COMM | 00461U105 |
| ACAD | ACADIA Pharmaceuticals Inc | 155,576 | $4.159M | 0.4% | $26.73 * | $25.54 | 0.0% | COMM | 004225108 |
| — | Zymeworks Inc | 188,057 | $4.137M | 0.4% | $22.00 | $22.00 | — | COMM | 98985W102 |
| AKBA | Akebia Therapeutics Inc | 848,356 | $4.106M | 0.4% | $4.84 * | $6.40 | -11.2% | COMM | 00972D105 |
| QURE | Uniqure NV | 50,000 | $3.908M | 0.4% | $78.16 | — | — | Call | N90064101 |
| — | Otonomy Inc | 1,337,568 | $3.679M | 0.3% | $2.75 | $2.83 | — | COMM | 68906L105 |
| — | ArQule Inc | 281,857 | $3.103M | 0.3% | $11.01 | $4.79 | — | COMM | 04269E107 |
| — | Foamix Pharmaceuticals Ltd | 1,115,810 | $2.655M | 0.2% | $2.38 | $4.53 | — | COMM | M46135105 |
| XBIT | XBiotech Inc | 331,811 | $2.515M | 0.2% | $7.58 | $7.09 | +5.6% | COMM | 98400H102 |
| — | Zogenix Inc | 50,000 | $2.389M | 0.2% | $47.78 | — | — | Call | 98978L904 |
| — | Intra-Cellular Therapies Inc | 175,000 | $2.271M | 0.2% | $12.98 | — | — | Call | 46116X901 |
| SNDX | Syndax Pharmaceuticals Inc | 242,729 | $2.26M | 0.2% | $9.31 * | $6.52 | +11.7% | COMM | 87164F105 |
| — | Deciphera Pharmaceuticals Inc | 100,100 | $2.258M | 0.2% | $22.56 | — | — | Put | 24344T951 |
| — | Adverum Biotechnologies Inc | 187,059 | $2.225M | 0.2% | $11.89 | $6.23 | — | COMM | 00773U108 |
| ABBV | AbbVie Inc | 28,911 | $2.103M | 0.2% | $72.74 * | $59.38 | 0.0% | COMM | 00287Y109 |
| — | Calithera Biosciences Inc | 529,839 | $2.066M | 0.2% | $3.90 | $3.90 | — | COMM | 13089P101 |
| ALNY | Alnylam Pharmaceuticals Inc | 27,792 | $2.017M | 0.2% | $72.57 * | $83.64 | -8.3% | COMM | 02043Q107 |
| RVLPQ | Osmotica Pharmaceuticals PLC | 525,198 | $1.996M | 0.2% | $3.80 * | $5.58 | -40.4% | COMM | G6S41R101 |
| — | Kala Pharmaceuticals Inc | 297,250 | $1.897M | 0.2% | $6.38 | $6.33 | — | COMM | 483119103 |
| — | Clovis Oncology Inc | 125,303 | $1.864M | 0.2% | $14.88 | $16.52 | — | COMM | 189464100 |
| — | Intra-Cellular Therapies Inc | 125,955 | $1.635M | 0.2% | $12.98 | $12.98 | — | COMM | 46116X101 |
| BCRX | BioCryst Pharmaceuticals Inc | 426,400 | $1.616M | 0.1% | $3.79 * | $6.02 | 0.0% | COMM | 09058V103 |
| — | Acorda Therapeutics Inc | 194,036 | $1.488M | 0.1% | $7.67 | $7.67 | — | COMM | 00484M106 |
| — | Forty Seven Inc | 118,803 | $1.259M | 0.1% | $10.60 | $10.60 | — | COMM | 34983P104 |
| APLS | Apellis Pharmaceuticals, Inc | 49,580 | $1.256M | 0.1% | $25.33 * | $19.65 | +3.5% | COMM | 03753U106 |
| — | Applied Therapeutics Inc | 142,004 | $1.17M | 0.1% | $8.24 | $8.24 | — | COMM | 03828A101 |
| AUTL | Autolus Therapeutics PLC | 65,780 | $1.059M | 0.1% | $16.10 | $16.10 | — | ADR | 05280R100 |
| PDSB | PDS Biotechnology Corporation | 142,635 | $854K | 0.1% | $5.99 * | $8.36 | -21.8% | COMM | 70465T107 |